What infections does cefpodoxime proxetil treat on the FDA label?
Cefpodoxime proxetil (a third-generation oral cephalosporin) is labeled for treatment of several common bacterial infections, including respiratory tract infections, urinary tract infections, and certain skin and skin-structure infections. The exact indications listed on the FDA-approved label are the ones clinicians use for on-label prescribing. [1]
Which respiratory infections are covered by the label?
The FDA label includes respiratory indications such as infections involving the lower respiratory tract and other susceptible respiratory infections (the label specifies which pathogens and clinical conditions qualify). [1]
Which urinary tract infections are covered?
The FDA label includes urinary tract infections (UTIs) caused by susceptible organisms. This includes specific UTI categories described on the label rather than all possible UTIs. [1]
What skin or skin-structure infections does it cover?
The FDA label includes skin and skin-structure infections due to susceptible bacteria, again tied to the label’s described clinical conditions and organisms. [1]
What does the FDA label say about dosing and who can take it?
Cefpodoxime proxetil dosing on the FDA label depends on the infection being treated and the patient’s age/weight category. The label also covers important prescribing details such as duration of therapy and how to use the medicine in appropriate populations. [1]
What to check before prescribing (allergy and safety items on the label)
Because cefpodoxime is a beta-lactam antibiotic, the FDA label includes key safety information clinicians check before use—especially allergy history to cephalosporins/penicillins and risk of serious hypersensitivity reactions. [1]
Where to read the exact FDA label wording (so you can confirm indications)
To see the precise list of FDA-labeled infections (and the exact wording for respiratory, urinary, and skin indications), use the FDA label/labeling document for cefpodoxime proxetil. [1]
---
Sources
[1] https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016333